Patrick R. Trucchio
Stock Analyst at HC Wainwright & Co.
(4.38)
# 344
Out of 5,056 analysts
39
Total ratings
62.16%
Success rate
16.81%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick R. Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ONCY Oncolytics Biotech | Maintains: Buy | $5 → $10 | $1.05 | +852.38% | 1 | Nov 17, 2025 | |
| CYBN Cybin | Maintains: Buy | $150 → $55 | $6.07 | +806.10% | 1 | Nov 14, 2025 | |
| PHVS Pharvaris | Reiterates: Buy | $60 | $24.92 | +140.77% | 2 | Nov 13, 2025 | |
| VYGR Voyager Therapeutics | Maintains: Buy | $30 → $25 | $4.11 | +508.27% | 2 | Nov 12, 2025 | |
| GHRS GH Research | Maintains: Buy | $40 → $35 | $14.10 | +148.23% | 1 | Nov 10, 2025 | |
| QURE uniQure | Maintains: Buy | $110 → $70 | $30.33 | +130.79% | 5 | Nov 4, 2025 | |
| IVVD Invivyd | Maintains: Buy | $5 → $10 | $2.84 | +252.11% | 3 | Nov 3, 2025 | |
| ANRO Alto Neuroscience | Maintains: Buy | $10 → $50 | $13.80 | +262.32% | 2 | Oct 24, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $36.57 | +173.45% | 1 | Oct 22, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $4.19 | +186.40% | 2 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $2.11 | +1,795.73% | 3 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $36.33 | +37.63% | 1 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $22.02 | +263.31% | 2 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $570 | $460.54 | +23.77% | 2 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $40.15 | +99.25% | 2 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $55 | $33.97 | +61.91% | 1 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $3.96 | +278.79% | 1 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $6.70 | +1,019.40% | 1 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.49 | +173.22% | 1 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $58.00 | +46.55% | 2 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $7.02 | +612.25% | 2 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.41 | +2,333.09% | 1 | Sep 4, 2025 |
Oncolytics Biotech
Nov 17, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $1.05
Upside: +852.38%
Cybin
Nov 14, 2025
Maintains: Buy
Price Target: $150 → $55
Current: $6.07
Upside: +806.10%
Pharvaris
Nov 13, 2025
Reiterates: Buy
Price Target: $60
Current: $24.92
Upside: +140.77%
Voyager Therapeutics
Nov 12, 2025
Maintains: Buy
Price Target: $30 → $25
Current: $4.11
Upside: +508.27%
GH Research
Nov 10, 2025
Maintains: Buy
Price Target: $40 → $35
Current: $14.10
Upside: +148.23%
uniQure
Nov 4, 2025
Maintains: Buy
Price Target: $110 → $70
Current: $30.33
Upside: +130.79%
Invivyd
Nov 3, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $2.84
Upside: +252.11%
Alto Neuroscience
Oct 24, 2025
Maintains: Buy
Price Target: $10 → $50
Current: $13.80
Upside: +262.32%
Immunocore Holdings
Oct 22, 2025
Reiterates: Buy
Price Target: $100
Current: $36.57
Upside: +173.45%
Altimmune
Oct 20, 2025
Reiterates: Buy
Price Target: $12
Current: $4.19
Upside: +186.40%
Oct 16, 2025
Reiterates: Buy
Price Target: $40
Current: $2.11
Upside: +1,795.73%
Oct 14, 2025
Reiterates: Buy
Price Target: $50
Current: $36.33
Upside: +37.63%
Oct 10, 2025
Reiterates: Buy
Price Target: $80
Current: $22.02
Upside: +263.31%
Oct 10, 2025
Reiterates: Buy
Price Target: $570
Current: $460.54
Upside: +23.77%
Oct 8, 2025
Reiterates: Buy
Price Target: $80
Current: $40.15
Upside: +99.25%
Sep 25, 2025
Maintains: Buy
Price Target: $70 → $55
Current: $33.97
Upside: +61.91%
Sep 23, 2025
Reiterates: Buy
Price Target: $15
Current: $3.96
Upside: +278.79%
Sep 16, 2025
Reiterates: Buy
Price Target: $75
Current: $6.70
Upside: +1,019.40%
Sep 15, 2025
Reiterates: Buy
Price Target: $15
Current: $5.49
Upside: +173.22%
Sep 15, 2025
Reiterates: Buy
Price Target: $85
Current: $58.00
Upside: +46.55%
Sep 12, 2025
Reiterates: Buy
Price Target: $50
Current: $7.02
Upside: +612.25%
Sep 4, 2025
Reiterates: Buy
Price Target: $10
Current: $0.41
Upside: +2,333.09%